Obálka a obsah
Typ dokumentu
články
články
Záznam dokumentu
Zdroj: BMČ - články
Název
30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post-MONICA, 1985 - 2016/17 / R. Cífková, J. Bruthans, P. Wohlfahrt, A. Krajčoviechová, P. Šulc, M. Jozífová, L. Eremiášová, J. Pudil, A. Linhart, J. Widimský, J. Filipovský, O. Mayer, Z. Škodová, R. Poledne, P. Stávek, V. Lánská,
Autor
Cifková, Renata
Center for Cardiovascular Prevention, First Faculty of Medicine and Thomayer Hospital, Charles University in Prague, Prague, Czech Republic. Department of Medicine II, Charles University in Prague, First Faculty of Medicine, Prague, Czech Republic.

Bruthans, Jan
Center for Cardiovascular Prevention, First Faculty of Medicine and Thomayer Hospital, Charles University in Prague, Prague, Czech Republic.

Wohlfahrt, Peter
Center for Cardiovascular Prevention, First Faculty of Medicine and Thomayer Hospital, Charles University in Prague, Prague, Czech Republic.

Krajčoviechová, Alena
Center for Cardiovascular Prevention, First Faculty of Medicine and Thomayer Hospital, Charles University in Prague, Prague, Czech Republic.

Šulc, Pavel
Center for Cardiovascular Prevention, First Faculty of Medicine and Thomayer Hospital, Charles University in Prague, Prague, Czech Republic.

Jozífová, Marie
Center for Cardiovascular Prevention, First Faculty of Medicine and Thomayer Hospital, Charles University in Prague, Prague, Czech Republic.

Eremiášová, Lenka
Department of Medicine II, Charles University in Prague, First Faculty of Medicine, Prague, Czech Republic.

Pudil, Jan
Department of Medicine II, Charles University in Prague, First Faculty of Medicine, Prague, Czech Republic.

Linhart, Aleš
Department of Medicine II, Charles University in Prague, First Faculty of Medicine, Prague, Czech Republic.

Widimský, Jiří
Department of Medicine III, Charles University in Prague, First Faculty of Medicine, Prague, Czech Republic.

Filipovský, Jan
Department of Medicine II, Faculty of Medicine, Charles University, Pilsen, Czech Republic.

Mayer, Otto
Department of Medicine II, Faculty of Medicine, Charles University, Pilsen, Czech Republic.

Škodová, Zdenka
Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Poledne, Rudolf
Atherosclerosis Research Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Stávek, Petr
Atherosclerosis Research Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Lánská, Věra
Medical Statistics Unit, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Zdroj
PLoS One. 2020, roč. 15, č. 5, e0232845. ISSN: 1932-6203; (OCoLC)70662135.
Datum vydání
2020
Jazyk
angličtina
Země
Spojené státy americké
Typ dokumentu
články
DOI
Pubmed ID
Odkaz
Číslo záznamu
bmc20025018
Persistentní link
Abstrakt anglicky
BACKGROUND: Compared with Western Europe, the decline in cardiovascular (CV) mortality has been delayed in former communist countries in Europe, including the Czech Republic. We have assessed longitudinal trends in major CV risk factors in the Czech Republic from 1985 to 2016/17, covering the transition from the totalitarian regime to democracy. METHODS: There were 7 independent cross-sectional surveys for major CV risk factors conducted in the Czech Republic in the same 6 country districts within the WHO MONICA Project (1985, 1988, 1992) and the Czech post-MONICA study (1997/98, 2000/01, 2007/08 and 2016/2017), including a total of 7,606 males and 8,050 females. The population samples were randomly selected (1%, aged 25-64 years). RESULTS: Over the period of 31/32 years, there was a significant decrease in the prevalence of smoking in males (from 45.0% to 23.9%; p < 0.001) and no change in females. BMI increased only in males. Systolic and diastolic blood pressure decreased significantly in both genders, while the prevalence of hypertension declined only in females. Awareness of hypertension, the proportion of individuals treated by antihypertensive drugs and consequently hypertension control improved in both genders. A substantial decrease in total cholesterol was seen in both sexes (males: from 6.21 ± 1.29 to 5.30 ± 1.05 mmol/L; p < 0.001; females: from 6.18 ± 1.26 to 5.31 ± 1.00 mmol/L; p < 0.001). CONCLUSIONS: The significant improvement in most CV risk factors between 1985 and 2016/17 substantially contributed to the remarkable decrease in CV mortality in the Czech Republic.
Schránka
Další akce